Case Study: Expanding Availability of Healthcare Services
Brazil is an out-of- pocket market and patients often have to cover their own treatment expenses Therefore, access to medicines is directly tied to purchasing power. The Alcance program was developed through collaboration between Sanofi and a chain of accredited pharmacies and other companies, which offer special conditions for a broad range of products and services. It aims to provide educational services and expand access to diabetes treatment primarily for the middle/low tier of patients.
Sanofi managed to offer an integrated solution without which the patients’ needs cannot be addressed. Patients require more than just insulin; their medical expenses may also include monitoring devices, strips, needles, anti-diabetic oral drugs and other medicines to control cholesterol and hypertension. A one-off discount on our products does not increase patients’ access, as the total cost of diabetes treatment would still remain too high to bear individually. To meet this challenge, Alcance addresses the full range of products and services for diabetes therapy.
Results to Date
- This program was launched nationwide in November 2010 and currently has more than 14,500 active patients enrolled.
- More than 700 additional patients per month with low drop-out rate
- From 2,437 patients in January 2011 to 14,500 in May 2013
Much more than a tiered pricing program, Alcance illustrates the importance of taking into account the full treatment environment and establishing solid relationships with multiple stakeholders to help provide sustainable and long-term access to healthcare for patients.
Related Case Studies on Expanding Availability of Healthcare Services
- StarBem, Sanofi
- Differential Pricing to Address Affordability in Egypt, Roche
- Arogya Parivar (Hindi for “Healthy Family”), Novartis
- NGO Narmada Samagra’s River Ambulance and Water Testing Project, Merck Serono
- Janssen eMedical Advisor (JeMA) Platform for Sub-Saharan Africa, Janssen, the Pharmaceutical Companies of Johnson & Johnson
- Janssen Global Public Health HIV Medicines Access & Partnerships Program, Janssen, the Pharmaceutical Companies of Johnson & Johnson
- Bristol-Myers Squibb Agreement with Medicines Patent Pool to Increase Access to Atazanavir, Bristol-Myers Squibb
- Base of the Pyramid Innovation Project, Novo Nordisk
- Differential Pricing Policy for Least Developed Countries, Novo Nordisk
- Private Health Insurance for Cancer Treatment in China, Roche
- Janssen Global Access and Partnership Program (GAPP), Janssen, the Pharmaceutical Companies of Johnson & Johnson
- New Business Models to Increase Access in Developing Countries, GlaxoSmithKline
- Alcance, Sanofi
- SMS for Life, Novartis International AG